Literature DB >> 8783083

Outcome of residual cholesteatoma and hearing in mastoid surgery.

D Roden1, V F Honrubia, R Wiet.   

Abstract

OBJECTIVE: To review 12 years of the senior author's experience with mastoid surgery for cholesteatoma.
DESIGN: Retrospective review.
SETTING: Northwestern University Medical School.
METHODS: Available records included 97 mastoid procedures for cholesteatoma: 54 with intact canal-wall and 43 canal-wall-down. MAIN OUTCOME MEASURES: Residual cholesteatoma, pure-tone audiometry, and speech audiometry were compared for both groups.
RESULTS: Residual disease rate was 11 of 54 (20%) for intact canal-wall procedures and 2 of 43 (5%) for canal-wall-down procedures. Average follow-up was 2 years. Hearing was preserved postoperatively, and neither procedure demonstrated clear superiority in this regard.
CONCLUSION: While canal-wall-down mastoidectomy provides a lower residual disease rate with equal hearing outcome, the role of intact wall mastoidectomy remains a viable choice in certain clinical situations.

Entities:  

Mesh:

Year:  1996        PMID: 8783083

Source DB:  PubMed          Journal:  J Otolaryngol        ISSN: 0381-6605


  5 in total

1.  A Comparative Study of Outcomes and Quality of Life in Canal Wall up Mastoidectomies and Canal Wall down Mastoidectomies.

Authors:  Lisa Abraham; Ajay Philip; Anjali Lepcha; Ann Mary Augustine; Suma Susan Mathews; Roshna Rose Paul; Manju Deena Mammen
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-02-09

Review 2.  Long-term surgical and functional outcomes of the intact canal wall technique for middle ear cholesteatoma in the paediatric population.

Authors:  S C Prasad; C La Melia; M Medina; V Vincenti; A Bacciu; S Bacciu; E Pasanisi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-10       Impact factor: 2.124

3.  Middle ear mucosal regeneration by tissue-engineered cell sheet transplantation.

Authors:  Kazuhisa Yamamoto; Masayuki Yamato; Tsunetaro Morino; Hiroaki Sugiyama; Ryo Takagi; Yuichiro Yaguchi; Teruo Okano; Hiromi Kojima
Journal:  NPJ Regen Med       Date:  2017-03-24

4.  Trends and Healthcare Use Following Different Cholesteatoma Surgery Types in a National Cohort, 2003-2019.

Authors:  Zhen Jason Qian; Emma D Tran; Jennifer C Alyono; Alan G Cheng; Iram N Ahmad; Kay W Chang
Journal:  Otol Neurotol       Date:  2021-10-01       Impact factor: 2.619

5.  Hydroxyapatite granules used in the obliteration of mastoid cavities in rats.

Authors:  Rogério Hamerschmidt; Rafael Francisco dos Santos; João Cândido Araújo; Henrique Jorge Stahlke; Miguel Angelo Agulham; Ana Tereza Ramos Moreira; Marcos Mocellin
Journal:  Braz J Otorhinolaryngol       Date:  2011-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.